Bionik is a trailblazer in the research of medical robotics for patients that have neurological disorders.
Bionik has just announced that they have teamed up with IBM to develop an analytics platform that will use machine learning and other techniques to help accelerate neurological research and rehabilitation.
While it may sound like science fiction, Bionik is the innovator of the lower body exoskeleton called ARKE. This device helps people in wheelchairs and those without limbs rehabilitate and perhaps even walk again.
Bionik has announced that they will implement IBM’s cognitive computing platform.
“This collaboration is the genesis of a meeting nearly a year ago where we discussed the universal importance of big data,” says Michal Prywata, Co-founder and COO at Bionik.
“During our follow-on conversations we began to realize synergies and started to discuss potential ways in which we could work together to develop an intelligent analytics platform for ARKE,” Prywata added.
With IBM, Bionik will gain access to the following metrics:
- The Exoskeleton’s Performance
- On-Demand Patient Data
- Result’s from different ARKE Rehab Sites
With all of this data in one place, Bionik can begin to dig deeper into research which will enable them to create strategies for their patients.
“Our entrepreneurial access program focused on adoption of cognitive computing is perfectly suited for a pioneering robotics company such as Bionik,” says Leon Katsnelson, the Director and Chief Technology Officer of IBM Analytic Platform Emerging Technologies.
“IBM recognizes the potential of Bionik’s ARKE exoskeleton and is eager to assist Bionik in their quest to provide advanced data analytics to rehabilitation specialists anywhere, anytime, through IBM Cloud,” Katsnelson went on to say.
By using Big Data, Bionik believes that it can create a better quality of life for those who may need neurological rehabilitation.
IBM’s cloud may provide unique insights for Bionik’s researchers that could give society a breakthrough in the neurological disorders field.